Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review

COVID-19 vaccination using mRNA technology began at the end of 2020 in several countries, approximately 9 months after the WHO declared the new coronavirus a pandemic, and began in Japan at the end of February 2021. Several studies have reported FDG avidity in enlarged axillary lymph nodes as a spec...

Full description

Saved in:
Bibliographic Details
Published in:Global Health & Medicine 2021/06/30, Vol.3(3), pp.129-133
Main Authors: Minamimoto, Ryogo, Kiyomatsu, Tomomichi
Format: Article
Language:English
Subjects:
COVID-19
FDG
PET/CT
Review
vaccine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:COVID-19 vaccination using mRNA technology began at the end of 2020 in several countries, approximately 9 months after the WHO declared the new coronavirus a pandemic, and began in Japan at the end of February 2021. Several studies have reported FDG avidity in enlarged axillary lymph nodes as a specific feature of FDG-PET/CT imaging after COVID-19 vaccination. A major concern is that this finding could lead to a misdiagnosis in patients with various types of malignancy. We review the impact of COVID-19 vaccination on the management of patients scheduled for FDG-PET/CT in the setting of nationwide mass vaccination.
ISSN:2434-9186
2434-9194
DOI:10.35772/ghm.2021.01076